This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Adherence among newly initiated duloxetine patients varied modestly across the medical conditions for which it was used.
(PRWEB) February 13, 2014
ClinicoEconomics and Outcomes Research has published the original research Duloxetine treatment adherence across mental health and chronic pain conditions.
As corresponding author Dr. Able says, Our study applied a uniform administrative claims-based methodology to assess duloxetine adherence in the treatment of multiple chronic conditions.
Dr. Able continues, The results suggest that not just the drug or drugs of interest, but the conditions treated should be taken into account by health plans when measuring, monitoring, and comparing adherence rates with real-world data.
As Professor Colombo, Editor-in-Chief, explains This study applied a uniform methodology for measuring and comparing duloxetine adherence in the treatment of multiple chronic medical conditions. Adherence among newly initiated duloxetine patients varied modestly across the medical conditions for which it was used. These results may be useful in the determination of expectations of adherence and how it may differ for each of the conditions studied.
ClinicoEconomics and Outcomes Research is an international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage.
Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11577512.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.